ConductScience.org, home

Paper40652138

Efficacy of Dupilumab in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric real-life study.

Marco G and 11 others. Eur Arch Otorhinolaryngol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Efficacy of Dupilumab in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric real-life study. Papers, record 40652138. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40652138

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of Dupilumab in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric real-life study.
PubMed
Journal
Eur Arch Otorhinolaryngol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Multicenter Study, Observational Study
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marco GGovonihttps://orcid.org/0000-0003-1831-4406
2Arianna SSoncinihttps://orcid.org/0009-0009-1082-6598
3Domenico CCudahttps://orcid.org/0000-0003-2437-2872
4Gabriele OOretti
5Silvia LMLazio Maria
6Giulia ZZamboninihttps://orcid.org/0000-0002-5169-9478
7Sara UUgolinihttps://orcid.org/0000-0002-7920-895X
8Irene HHerman
9Celeste CCCarpentiero Colarusso
10Enrico LLiaci
11Enrico PPasanisi
12Daria SSalsi

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, Monoclonal, HumanizedMajor topic
Nasal PolypsMajor topic
RhinosinusitisMajor topic
Adult
Aged
Female
Humans
Male
Middle Aged
Chronic Disease
Eosinophils
Follow-Up Studies
Immunoglobulin E
Quality of Life
Treatment Outcome

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121605125Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study.Allergy2011https://conductscience.org/library/papers/21605125PubMed
238762844Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature.Eur Arch Otorhinolaryngol2024https://conductscience.org/library/papers/38762844PubMed
337234094Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy.World Allergy Organ J2023https://conductscience.org/library/papers/37234094PubMed
437111387Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37111387PubMed
532644117Contemporary Classification of Chronic Rhinosinusitis Beyond Polyps vs No Polyps: A Review.JAMA Otolaryngol Head Neck Surg2020https://conductscience.org/library/papers/32644117PubMed
637632705Influence of Prior Endoscopic Sinus Surgery Extent on Dupilumab Effectiveness in CRSwNP Patients.Laryngoscope2024https://conductscience.org/library/papers/37632705PubMed
735468866Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps.J Otolaryngol Head Neck Surg2022https://conductscience.org/library/papers/35468866PubMed
817084217Rhinosinusitis: developing guidance for clinical trials.J Allergy Clin Immunol2006https://conductscience.org/library/papers/17084217PubMed
922616073Prevalence of chronic rhinosinusitis in Sao Paulo.Rhinology2012https://conductscience.org/library/papers/22616073PubMed
1035490414High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients.Clin Exp Allergy2023https://conductscience.org/library/papers/35490414PubMed
118140385Staging in rhinosinusitus.Rhinology1993https://conductscience.org/library/papers/8140385PubMed
1236999780EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023.Rhinology2023https://conductscience.org/library/papers/36999780PubMed
1337543087Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab: Real-World Use and Outcomes.J Allergy Clin Immunol Pract2023https://conductscience.org/library/papers/37543087PubMed
143327855First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)--1922 (with a note on aspirin desensitization). By F. Widal, P. Abrami, J. Lermoyez.J Asthma1987https://conductscience.org/library/papers/3327855PubMed
1532077450European Position Paper on Rhinosinusitis and Nasal Polyps 2020.Rhinology2020https://conductscience.org/library/papers/32077450PubMed
1626302727Commentary on gender differences in prevalence, treatment, and quality of life of patients with chronic rhinosinusitis.Allergy Rhinol (Providence)2015https://conductscience.org/library/papers/26302727PubMed
1737674253The "real life" efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP.J Otolaryngol Head Neck Surg2023https://conductscience.org/library/papers/37674253PubMed
1819405090Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposis.Laryngoscope2009https://conductscience.org/library/papers/19405090PubMed
1936946589Dupilumab for chronic rhinosinusitis with nasal polyps: real-life retrospective 12-month effectiveness data.Rhinology2023https://conductscience.org/library/papers/36946589PubMed
2027393770Chronic Rhinosinusitis with Nasal Polyps.J Allergy Clin Immunol Pract2016https://conductscience.org/library/papers/27393770PubMed

See all 45 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn PapersSource
42964453Chronic Rhinosinusitis with Nasal Polyps: T-Cell Dysregulation and Regulatory T-Cell Dysfunction.Curr Otorhinolaryngol Rep2026https://conductscience.org/library/papers/42964453PubMed
42783669Does Patient-Reported Olfactory Improvement Correlate with Quality of Life and Polyp Size Reduction in Patients with CRSwNP Treated with Dupilumab?Medicines (Basel)2026https://conductscience.org/library/papers/42783669PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IGHE3497PubTator's text mininghttps://conductscience.org/library/genes/3497

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40652138

GET https://conductscience.org/api/papers/v1/40652138/references?page=2